Oncopeptides will host a webcast on Wednesday, December 9[th] at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting
STOCKHOLM — December 7, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases today announces that the company will host a webcast on Wednesday, December 9[th], 2020, at 14:00 (CET) to provide an update regarding the data presented December 4-8 at the American Society Hematology (ASH) Annual Meeting 2020.At ASH Oncopeptides has presented twelve abstracts, including one oral presentation. Key clinical abstracts focused on new data from the ongoing phase 1/2 ANCHOR
Frankenthal, Germany, December 7, 2020 - The RKW Group has switched its production sites in Germany to green electricity this year, thereby significantly expanding its commitment to sustainability once again. The use of clean energy has reduced CO\2\ emissions by around 80,000 tons in 2020. In relation to the power consumption of the German sites, this represents a reduction of around 80 percent. Calculated for the Group as a whole, CO\2\ emissions are around 40 percent lower.The production of films is an energy-intensive process, especially as the sites produce around the clock and
7 December 2020, Milton Keynes, UK. Mölnlycke announces the launch of a new UK distribution centre, strengthening customers’ access to quality Mölnlycke products via a new, more robust supply chain solution delivering environmental benefits.The timing of this new facility also provides reassurance of product supply at a time of uncertainty, where the true impact of Brexit on borders is unknown and the COVID-19 pandemic is ongoing. Mölnlycke’s top priority is on ensuring that healthcare professionals and patients continue to receive their vital supplies through these turbulent times.
The
